The results showed that in the CT26 colorectal cancer model, the DAC and 5-FU treatments significantly downregulated the expression of PD-1 and the MFI value in CD44+CD8+ TILs compared with the PBS control. This evidence concerns the gene CD44 and colorectal cancer.